Delivery Order SPE2DB22D2206-SPE2DB25FGT00
Award Date 4/25/25
Potential Completion Date 5/16/25
Potential Value $35K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a delivery order contract worth $49,752.80 for the supply of GAMUNEX-C 40 gram/400 ml vials. The contract has a firm fixed price and an ultimate completion date of January 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $10,988.46 by the Defense Logistics Agency (DLA) on October 8, 2025, for the supply of Gamunex-C 10 gram/100 milliliter vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 30, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,180.13 on August 6, 2025, for GAMUNEX-C 20 GR/200 1S, a specialized pharmaceutical product. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of August 27, 2025. The contract is funded through the Defense Logistics Agency's Medical Supply Chain, which procures...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 14, 2025, for the supply of Gamunex-C 40 gram/400 mL vials. The contract, valued at $46,544.00, carries a firm fixed price structure with an ultimate completion date of September 5, 2025. This award represents a non-set-aside competitive procurement and will be performed at the contractor's Conshohocken facility. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $111,705.60 to AmerisourceBergen Drug Corp for the supply of Gamunex-C, a 40-gram immunoglobulin product in 400 mL vials. The contract, awarded on September 29, 2025, represents a firm fixed-price delivery order with an ultimate completion date of October 21, 2025. This award was competitively solicited with no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Gamunex-C 10 gram/100 mL vials totaling $3,052.35 with a firm fixed price structure. The delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with DLA Troop Support Medical, is scheduled for completion by July 16, 2025. The award was made through open...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 5 gram/50 mL vials. The contract has a ceiling value of $3,036.70 and a period of performance through July 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...
- The Defense Logistics Agency awarded a $40,532.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 milliliter vials, with an ultimate completion date of August 22, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a $28,323.36 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Gamunex-C 20 gram/200 mL vials. This is a firm fixed price, non-set-aside contract with a completion date of October 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement needs,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 21, 2025, for the supply of Gamunex-C 20 gram/200 milliliter vials with a ceiling value of $28,323.36. This firm fixed-price delivery order is set to be completed by September 12, 2025, and was awarded through the Defense Logistics Agency's Medical Supply Chain without the use of a set-aside designation, indicating it was competitively awarded. The...